BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17505925)

  • 21. Self-reported adherence to single dose nevirapine in the prevention of mother to child transmission of HIV at Kitale District Hospital.
    Bii SC; Otieno-Nyunya B; Siika A; Rotich JK
    East Afr Med J; 2007 Dec; 84(12):571-6. PubMed ID: 18402309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: adherence to the postnatal PMTCT program.
    Nassali M; Nakanjako D; Kyabayinze D; Beyeza J; Okoth A; Mutyaba T
    AIDS Care; 2009 Sep; 21(9):1124-31. PubMed ID: 20024771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Socio-demographic factors associated with loss to follow-up of HIV-infected women attending a private sector PMTCT program in Maharashtra, India.
    Panditrao M; Darak S; Kulkarni V; Kulkarni S; Parchure R
    AIDS Care; 2011 May; 23(5):593-600. PubMed ID: 21293983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
    Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with short-course antiretroviral prophylaxis (dual therapy) adherence for PMTCT in Nkangala district, South Africa.
    Peltzer K; Sikwane E; Majaja M
    Acta Paediatr; 2011 Sep; 100(9):1253-7. PubMed ID: 21366691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Safe Motherhood project in Kenya: assessment of antenatal attendance, service provision and implications for PMTCT.
    Delva W; Yard E; Luchters S; Chersich MF; Muigai E; Oyier V; Temmerman M
    Trop Med Int Health; 2010 May; 15(5):584-91. PubMed ID: 20230571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of attrition among children born in a PMTCT programme in Zimbabwe followed up over 5 years.
    Kurewa NE; Gumbo FZ; Mapingure PM; Munjoma MW; Chirenje MZ; Rusakaniko S; Stray-Pedersen B
    J Trop Pediatr; 2012 Oct; 58(5):360-9. PubMed ID: 22262677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in greater Kingston, Jamaica.
    Johnson N; Mullings AA; Harvey KM; Alexander G; McDonald D; Smikle MF; Williams E; Palmer P; Whorms S; Figueroa JP; Christie CD
    West Indian Med J; 2004 Oct; 53(5):297-302. PubMed ID: 15675494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening.
    Rollins N; Little K; Mzolo S; Horwood C; Newell ML
    AIDS; 2007 Jun; 21(10):1341-7. PubMed ID: 17545711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementing a rural programme of prevention of mother-to-child transmission of HIV in Zimbabwe: first 18 months of experience.
    Perez F; Mukotekwa T; Miller A; Orne-Gliemann J; Glenshaw M; Chitsike I; Dabis F
    Trop Med Int Health; 2004 Jul; 9(7):774-83. PubMed ID: 15228487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
    Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
    AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.
    Eshleman SH; Hoover DR; Chen S; Hudelson SE; Guay LA; Mwatha A; Fiscus SA; Mmiro F; Musoke P; Jackson JB; Kumwenda N; Taha T
    J Infect Dis; 2005 Jul; 192(1):30-6. PubMed ID: 15942891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
    Eshleman SH; Hoover DR; Hudelson SE; Chen S; Fiscus SA; Piwowar-Manning E; Jackson JB; Kumwenda NI; Taha TE
    J Infect Dis; 2006 Feb; 193(4):479-81. PubMed ID: 16425125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe.
    Zijenah LS; Kadzirange G; Rusakaniko S; Kufa T; Gonah N; Tobaiwa O; Gwanzura C; Matsikire E; Katzenstein DA
    Cent Afr J Med; 2006; 52(1-2):1-8. PubMed ID: 17892232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors determining HIV viral testing of infants in the context of mother-to-child transmission.
    Peltzer K; Mlambo G
    Acta Paediatr; 2010 Apr; 99(4):590-6. PubMed ID: 20064134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevention of mother-to-child HIV transmission programme in Lilongwe, Malawi: why do so many women drop out.
    Chinkonde JR; Sundby J; Martinson F
    Reprod Health Matters; 2009 May; 17(33):143-51. PubMed ID: 19523591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study offers hope for Africa's next generation.
    WORLD; 1999 Sep; (No 101):4-5. PubMed ID: 11366948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nevirapine resistance after single dose prophylaxis.
    Eshleman SH; Jackson JB
    AIDS Rev; 2002; 4(2):59-63. PubMed ID: 12152519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up survey of women who have undergone a prevention of mother-to-child transmission program in a resource-poor setting in South Africa.
    Peltzer K; Mosala T; Dana P; Fomundam H
    J Assoc Nurses AIDS Care; 2008; 19(6):450-60. PubMed ID: 19007723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?
    Sint TT; Dabis F; Kamenga C; Shaffer N; de Zoysa IF
    Bull World Health Organ; 2005 Mar; 83(3):224-8. PubMed ID: 15798847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.